- 专利标题： Modified release formulations of a bupropion salt
-
申请号： US11475252申请日： 2006-06-27
-
公开(公告)号： US20070027213A1公开(公告)日： 2007-02-01
- 发明人: Werner Oberegger , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Ashty
- 申请人： Werner Oberegger , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Ashty
- 申请人地址： CA Mississauga
- 专利权人： Biovail Laboratories International S.R.L.
- 当前专利权人： Biovail Laboratories International S.R.L.
- 当前专利权人地址： CA Mississauga
- 主分类号： A61K31/195
- IPC分类号： A61K31/195
摘要：
The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
公开/授权文献
- US07241805B2 Modified release formulations of a bupropion salt 公开/授权日：2007-07-10
信息查询
